Active Ingredient(s):Tocilizumab FDA Approved: * January 8, 2010 Pharm Company: *GENENTECH Category:Arthritis
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and pros...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion